Design Therapeutics

OverviewSuggest Edit

Design Therapeutics is a biotechnology company that develops therapies for serious degenerative disorders caused by nucleotide repeat expansions. It specializes in the development of treatment for Friedreich's ataxia and degenerative diseases such as Fragile X syndrome and myotonic dystrophy.

TypePublic
Founded2017
HQCarlsbad, CA, US
Websitedesigntx.com

Latest Updates

Employees (est.) (Mar 2021)22
Share Price (Nov 2021)$20(-1%)
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Design Therapeutics

Pratik Shah

Pratik Shah

Co-Founder & Executive Chairman, Director
João Siffert

João Siffert

President, Chief Executive Officer & Director
Sean Jeffries

Sean Jeffries

Chief Operating Officer
Simeon George

Simeon George

Director
Rodney Lappe

Rodney Lappe

Director
Stella Xu

Stella Xu

Director
Show more

Design Therapeutics Office Locations

Design Therapeutics has offices in Carlsbad, New York and San Diego
Carlsbad, CA, US (HQ)
6005 Hidden Valley Rd Suite 110
New York, NY, US
59 Maiden Ln
San Diego, CA, US
4365 Executive Dr # 1600
San Diego, CA, US
4401 Eastgate Mall
Show all (4)

Design Therapeutics Financials and Metrics

Design Therapeutics Revenue

Market capitalization (12-Nov-2021)

1.1b

Closing stock price (12-Nov-2021)

20.0
Design Therapeutics's current market capitalization is $1.1 b.
Show all financial metrics

Design Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

A

95/100

SecurityScorecard logo

Design Therapeutics Online and Social Media Presence

Embed Graph

Design Therapeutics News and Updates

Design Therapeutics Announces Positive Preclinical Data Highlighting Disease-Modifying Potential of its Novel DM1 GeneTACs as a Treatment for Myotonic Dystrophy Type-1

Data to be Presented during the 2021 Virtual Myotonic Dystrophy Foundation Annual Conference Data to be Presented during the 2021 Virtual Myotonic Dystrophy Foundation Annual Conference

Design Therapeutics to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference

CARLSBAD, Calif., June 07, 2021 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a biotechnology company developing treatments for degenerative genetic disorders, today reported that João Siffert, M.D., president and chief executive officer, will participate in a fireside chat during …

Design Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

CARLSBAD, Calif., March 30, 2021 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN) (“Design”), a biotechnology company developing a platform of gene targeted chimera (GeneTAC™) small molecules for the treatment of serious degenerative disorders caused by inherited nucleotide repeat expa…

Design Therapeutics Announces Pricing of Initial Public Offering

CARLSBAD, Calif., March 25, 2021 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc., a biotechnology company developing a platform of gene targeted chimera (GeneTAC™) small molecules for the treatment of serious degenerative disorders caused by inherited nucleotide repeat expansions, today announced th…

Design Therapeutics sets IPO terms, to be valued at more than $1 billion

Design Therapeutics Inc. has set terms for its initial public offering, in which the California-based biopharmaceutical company focused on gene targeted chimeras (GeneTAC) expects to raise up to $240 million, and be valued at up to $1.08 billion. The company is offering 12 million share in the IPO,…

Design Therapeutics Frequently Asked Questions

  • When was Design Therapeutics founded?

    Design Therapeutics was founded in 2017.

  • Who are Design Therapeutics key executives?

    Design Therapeutics's key executives are Pratik Shah, João Siffert and Sean Jeffries.

  • How many employees does Design Therapeutics have?

    Design Therapeutics has 22 employees.

  • Who are Design Therapeutics competitors?

    Competitors of Design Therapeutics include Albumedix, Genexine and Antibe Therapeutics.

  • Where is Design Therapeutics headquarters?

    Design Therapeutics headquarters is located at 6005 Hidden Valley Rd Suite 110, Carlsbad.

  • Where are Design Therapeutics offices?

    Design Therapeutics has offices in Carlsbad, New York and San Diego.

  • How many offices does Design Therapeutics have?

    Design Therapeutics has 4 offices.